NasdaqGS - Nasdaq Real Time Price USD

Intuitive Surgical, Inc. (ISRG)

Compare
428.77 +2.99 (+0.70%)
As of 12:32 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
7,318,500.00
7,124,100.00
6,222,200.00
5,710,100.00
4,358,400.00
--
Cost of Revenue
2,456,600.00
2,394,600.00
2,026,200.00
1,751,600.00
1,497,200.00
--
Gross Profit
4,861,900.00
4,729,500.00
4,196,000.00
3,958,500.00
2,861,200.00
--
Operating Expense
3,013,300.00
2,962,700.00
2,618,900.00
2,137,500.00
1,811,400.00
--
Operating Income
1,848,600.00
1,766,800.00
1,577,100.00
1,821,000.00
1,049,800.00
--
Net Non Operating Interest Income Expense
227,000.00
192,100.00
29,700.00
69,300.00
157,200.00
--
Pretax Income
2,075,600.00
1,958,900.00
1,606,800.00
1,890,300.00
1,207,000.00
--
Tax Provision
71,700.00
141,600.00
262,400.00
162,200.00
140,200.00
--
Net Income Common Stockholders
1,987,600.00
1,798,000.00
1,322,300.00
1,704,600.00
1,060,600.00
--
Diluted NI Available to Com Stockholders
1,987,600.00
1,798,000.00
1,322,300.00
1,704,600.00
1,060,600.00
--
Basic EPS
5.65
5.12
3.72
4.79
3.02
--
Diluted EPS
5.54
5.03
3.65
4.66
2.94
--
Basic Average Shares
352,025.00
351,200.00
355,700.00
356,100.00
351,000.00
--
Diluted Average Shares
358,525.00
357,400.00
362,000.00
365,800.00
360,900.00
--
Total Operating Income as Reported
1,848,600.00
1,766,800.00
1,577,100.00
1,821,000.00
1,049,800.00
--
Total Expenses
5,469,900.00
5,357,300.00
4,645,100.00
3,889,100.00
3,308,600.00
--
Net Income from Continuing & Discontinued Operation
1,987,600.00
1,798,000.00
1,322,300.00
1,704,600.00
1,060,600.00
--
Normalized Income
1,987,600.00
1,798,000.00
1,322,300.00
1,704,600.00
1,060,600.00
--
Interest Income
--
192,100.00
29,700.00
69,300.00
157,200.00
--
Net Interest Income
227,000.00
192,100.00
29,700.00
69,300.00
157,200.00
--
EBIT
1,848,600.00
1,766,800.00
1,577,100.00
1,821,000.00
1,049,800.00
--
EBITDA
2,287,000.00
2,188,600.00
1,942,900.00
2,131,200.00
1,326,000.00
--
Reconciled Cost of Revenue
2,456,600.00
2,394,600.00
2,026,200.00
1,751,600.00
1,497,200.00
--
Reconciled Depreciation
438,400.00
421,800.00
365,800.00
310,200.00
276,200.00
--
Net Income from Continuing Operation Net Minority Interest
1,987,600.00
1,798,000.00
1,322,300.00
1,704,600.00
1,060,600.00
--
Normalized EBITDA
2,287,000.00
2,188,600.00
1,942,900.00
2,131,200.00
1,326,000.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
12/31/2019 - 6/16/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BDX Becton, Dickinson and Company
233.56
-0.07%
 
RMD ResMed Inc.
210.53
-0.57%
 
WST West Pharmaceutical Services, Inc.
336.80
+1.07%
 
RGEN Repligen Corporation
124.03
-1.27%
 
BAX Baxter International Inc.
33.94
+0.47%
 
BNGO Bionano Genomics, Inc.
0.8038
-3.14%
 
HOLX Hologic, Inc.
71.66
-0.18%
 
STAA STAAR Surgical Company
39.55
-4.05%
 
LUCY Innovative Eyewear, Inc.
0.4241
+1.18%
 
COO The Cooper Companies, Inc.
92.30
-1.25%